Lessons from the Pandemic: COVID-19 and Health-Pharma Investigations

During the COVID-19 pandemic, journalists worldwide were suddenly thrown into the public health beat, trying to make sense of competing claims, and a science that seemed to change by the day. A session at the GIJC21 walked reporters through the COVID-19 pandemic, offering tips on covering the drug development and approval processes, evaluating scientific studies, unearthing conflicts of interest, and exposing fraud and malpractice.

How Nonprofit Newsrooms Pioneered In-Depth Healthcare Coverage Before the Pandemic

When the COVID-19 pandemic took hold last year, editors scrambled to rapidly assemble teams to cover the crisis. Steps ahead were the outlets already dedicated to investigating health as a subject who knew how to source and build networks of public health and vaccine experts, and crucially, how to investigate both the science and the politics behind the pandemic response.